Home › Funds › Two Sigma Investments › DSGN
Two Sigma Investments position in DSGN
DESIGN THERAPEUTICS INC · Health Care
Latest position (Q2 2026)32.92K sh
Reported value held$476.43K
Portfolio Weight0.00%
First reportedQ4 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2022 | 35.09K | $360.05K | New |
| Q1 2023 | 179.10K | $1.03M | Add |
| Q2 2023 | 115.78K | $729.43K | Reduce |
| Q3 2023 | 63.84K | $150.65K | Reduce |
| Q4 2023 | 428.17K | $1.13M | Add |
| Q1 2024 | 422.04K | $1.70M | Reduce |
| Q2 2024 | 402.71K | $1.35M | Reduce |
| Q3 2024 | 304.24K | $1.64M | Reduce |
| Q4 2024 | 203.93K | $1.26M | Reduce |
| Q1 2025 | 128.75K | $496.96K | Reduce |
| Q2 2025 | 89.31K | $300.98K | Reduce |
| Q3 2025 | 59.24K | $446.06K | Reduce |
| Q4 2025 | 46.24K | $433.70K | Reduce |
| Q1 2026 | 16.30K | $173.43K | Reduce |
| Q2 2026 | 32.92K | $476.43K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding DSGN
- BlackRock Inc 2.66M sh · $38.49M · Q2 2026
- Point72 Asset Management 2.37M sh · $34.24M · Q2 2026
- Vanguard Group 1.63M sh · $15.30M · Q4 2025
- Geode Capital Management 958.42K sh · $13.87M · Q2 2026
- Fidelity Management & Research (FMR) 776.46K sh · $11.24M · Q2 2026
- Morgan Stanley 765.42K sh · $11.08M · Q2 2026
- Goldman Sachs Group 656.58K sh · $9.50M · Q2 2026
- Renaissance Technologies 387.91K sh · $5.61M · Q2 2026
- Northern Trust Corp 353.20K sh · $5.11M · Q2 2026
- Charles Schwab Investment Management 271.26K sh · $3.93M · Q2 2026
- Prudential Financial 224.17K sh · $3.24M · Q2 2026
- D. E. Shaw & Co 195.65K sh · $2.83M · Q2 2026